Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome--11beta-hydroxysteroid dehydrogenase type 1

Clin Med (Lond). 2005 Mar-Apr;5(2):142-6. doi: 10.7861/clinmedicine.5-2-142.

Author

Paul M Stewart¹

Affiliation

¹ Division of Medical Sciences, Institute of Biomedical Research, Medical School, University of Birmingham.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors
11-beta-Hydroxysteroid Dehydrogenase Type 1 / metabolism*
Adipose Tissue / enzymology*
Animals
Biomarkers / metabolism
Cushing Syndrome / complications
Cushing Syndrome / enzymology*
Glucocorticoids / therapeutic use
Humans
Liver / enzymology*
Metabolic Syndrome / drug therapy*
Metabolic Syndrome / enzymology
Metabolic Syndrome / etiology

Substances

Biomarkers
Glucocorticoids
11-beta-Hydroxysteroid Dehydrogenase Type 1